Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
Dr. David Mikulis, neuroradiologist with the Joint Department of Medical Imaging at the Krembil Neuroscience Centre, has received a grant to investigate one of the hottest topics in the field of neuroradiology: the imaging of dementia.
The prestigious grant from the Foundation of the American Society of Neuroradiology (ASNR) will allow Dr. Mikulis to study cerebral vascular function in search of an imaging biomarker that can help with the early detection of Alzheimer's disease.
"In our preliminary studies, patients with early cognitive impairment, years before the development of Alzheimer's disease, have slower opening of their brain blood vessels that correlates directly with how well the brain is functioning," said Dr. Mikulis, who is also a senior scientist at the Krembil Research Institute.
"We think this could become a marker of an early stage of the disease."
Contributing factors to Alzheimer's disease
Obesity, high blood pressure, smoking, diabetes, inactivity and elevated blood cholesterol levels are all vascular risk factors that can damage blood vessels, subsequently reducing their ability to properly adjust blood flow in the brain. When this happens, the coupling of brain blood flow to brain activity is impaired. This leaves neurons starved for blood.
"This is one of the features that we believe contributes to Alzheimer's disease," says Dr. Mikulis, whose research uses brain imaging, specifically MRI (Magnetic Resonance Imaging), to observe the effects of blood flow on connecting fibers in the brain.
"Think of a plant in the summer. If it doesn't get enough water it may not die, but instead, it starts to wither and shrivel," says Dr. Mikulis.
"That's what we think is happening to the complexity of the brain connections leading to a decrease in cognitive function. The brain simply isn't working as well as it could."
Benefits of early detection
Dr. Mikulis also theorizes that inadequate blood flow can lead to a buildup of amyloid protein in the brain. "This is nasty stuff and you don't want it to accumulate. It kills neurons eventually leading to Alzheimer's disease."
If these vascular problems can be detected earlier, Dr. Mikulis believes it might be possible to devise a treatment that can delay or stop the progression of the disease before it is too late.
The ASNR grant will allow Dr. Mikulis to study vascular function in search of an imaging biomarker for two years and will include contributions by researchers at the University of Toronto and John Hopkins University.